Çağatay Arslan - Faculty of Medicine, Suleyman Demirel University

基本信息

浏览量：12

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 188 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Evaluating the Prognostic Role of Glucose-to-lymphocyte Ratio in Patients with Metastatic Renal Cell Carcinoma Treated with Tyrosine Kinase Inhibitors in First Line: a Study by the Turkish Oncology Group Kidney Cancer Consortium (TKCC)

Hatice Bolek,Omer Faruk Kuzu, Elif Sertesen Camoz, Saadet Sim,Serhat Sekmek,Hilal Karakas,Selver Isık, Murat Günaltılı, Aysun Fatma Akkus,Deniz Tural,Cagatay Arslan, Sema Sezin Goksu,Ozlem Nuray Sever, Nuri Karadurmus,Cengiz Karacin,Mehmet Ali Nahit Sendur,Emre Yekedüz,Yuksel Urun

Clinical and Translational Oncologypp.1-11, (2025)

引用0浏览0WOS引用

Comparison of Two Alternative Sequences with Cabazitaxel and 177Lu-Psma-617 in Metastatic Castration-Resistant Prostate Cancer: A Retrospective Multicenter Study (Lucas)

Hatice Bolek,Satı Coskun Yazgan,Furkan Ceylan,Jorge Esteban-Villarrubia,Cagatay Arslan,Tülay Kuş,Deniz Tural,Mehmet Ali Nahit Sendur,Nuriye Ozlem Kucuk, Elif Çıngı Özdemir,Elena Castro,Emre Yekedüz,Yüksel Ürün

European Journal of Cancerpp.115226, (2025)

引用0浏览0WOS引用

Sunitinib in Metastatic Renal Cell Carcinoma: Clinical Outcomes Across Risk Groups in a Turkish Oncology Group Kidney Cancer Consortium

Hatice Bolek,Omer Faruk Kuzu, Elif Sertesen Camoz, Saadet Sim,Serhat Sekmek,Hilal Karakas,Selver Isık,Murad Guliyev, Aysun Fatma Akkus,Deniz Tural,Cagatay Arslan, Sema Sezin Goksu,Ozlem Nuray Sever, Nuri Karadurmus,Cengiz Karacin,Mehmet Ali Nahit Sendur,Emre Yekedüz,Yuksel Urun

Cancer communications (London, England) (2025)

引用0浏览0WOS引用

Advancements in Platinum Chemotherapy for Metastatic Castration-Resistant Prostate Cancer: Insights and Perspectives

Erman Akkuş,Çağatay Arslan,Yüksel Ürün

Cancer Treatment Reviewspp.102818, (2024)

引用0浏览0WOS引用

Comparison of the Efficacy of Sunitinib and Pazopanib in Patients with Advanced Non-Clear Renal Cell Carcinoma

Hasan Cagri Yildirim,Ertugrul Bayram,Elvin Chalabiyev,Nargiz Majidova,Tugay Avci,Halil Goksel Guzel,Caner Kapar,Mehmet Uzun, Perihan Perkin,Fahri Akgul, Saadet Sim Yildirim,Seda Sali,Anil Yildiz,Seher Nazli Kazaz,Engin Hendem,Murat Arcagok,Gulnihal Tufan, Umit Yildirim, Omer Faruk Akgul,Cagatay Arslan,Hakan Taban, Eren Sahin,Melek Caglayan,Ramazan Esen,Berna Oksuzoglu,Deniz Can Guven,Muhammet Ali Kaplan,Murat Araz,Mert Basaran,Erdem Cubukcu,Erhan Gokmen,Irfan Cicin,Efnan Algin,Huseyin Salih Semiz,Deniz Tural,Banu Ozturk,Atike Pinar Erdogan,Murat Sari,Oguz Kara,Mustafa Erman

Journal of Chemotherapypp.1-12, (2024)

引用0浏览0WOS引用

Abstract PO3-04-12: SUMIT-BC: Phase 2 randomized study of fulvestrant with or without the cyclin-dependent kinase 7 inhibitor (CDK7i) samuraciclib in advanced hormone receptor positive (HR+) breast cancer after CDK4/6i

Glen Clack,Sercan Aksoy,Meritxell Bellet- Ezquerra,Begoña Bermejo,Cagatay Arslan,Maria Castro-Henriques,Irfan Cicin,Mahmut Gumus, Carmen Hinojo-González,Nuri Karadurmus, Denisse Lee Cervantes,Rebeca Lozano Mejorada,Emmanuel de la Mora Jimenez,Fernando Moreno Antón,Sonia Pernas,Timothy Pluard, Carlos Zuloaga Fernandez del Valle,Ozan yazıcı,Stuart McIntosh

Cancer Researchno. 9_Supplement (2024): PO3-04

引用0浏览0引用

Immune Checkpoints Blockade Therapies' Efficacy and Toxicity in Patients with Impaired Renal Function in Metastatic Bladder Cancer

Deniz Tural,Cagatay Arslan,Fatih Selcukbiricik,Omer Fatih Olmez,Mustafa Erman,Yueksel Urun,Dilek Erdem,Saadettin Kilickap

Journal of Clinical Oncology（2024）

引用0浏览0引用

Abstract PO3-04-12: SUMIT-BC: Phase 2 Randomized Study of Fulvestrant with or Without the Cyclin-Dependent Kinase 7 Inhibitor (cdk7i) Samuraciclib in Advanced Hormone Receptor Positive (HR+) Breast Cancer after CDK4/6i

Glen Clack,Sercan Aksoy,Meritxell Bellet Ezquerra,Begoña Bermejo,Cagatay Arslan,Maria Castro-Henriques,İrfan Çiçin,Mahmut Gümüş, Carmen Hinojo-González,Nuri Karadurmuş, Denisse Lee Cervantes, R. Lozano Mejorada,Emmanuel de la Mora Jimenez,Fernando Moreno,Sònia Pernas,Timothy Pluard, Carlos Zuloaga Fernandez del Valle,O. Yazıcı,Stuart McIntosh

Cancer Researchno. 9_Supplement (2024): PO3-12

引用0浏览0引用

200P Outcomes of Patients (pts) with Unfavourable, Non-Squamous Cancer of Unknown Primary (CUP) Progressing after Induction Chemotherapy (CTX) in the Global, Open-Label, Phase II CUPISCO Study

T. Bochtler,A. Krämer,C. Pauli, G. Durán-Pacheco,C. Arslan,F. Bigot,N. Chalabi,N. Cook,A. Italiano,F. Losa, J. Menezes, N. Ma,M. Ozguroglu,R.A. Pazo Cid,J.S. Ross,K-K. Shiu, P. Arni,H. Moch,L. Mileshkin

Annals of Oncology (2024): S296-S297

引用0浏览0引用

Association Between Baseline and Changes in Early Neutrophil-to-Lymphocyte Ratio on Survival in Patients with Metastatic Bladder Carcinoma Treated with Immunotherapy

Ezgi Degerli,Cagatay Arslan,Fatih Selcukbiricik,Omer Fatih Olmez,Dilek Erdem,Jamshid Hamdard,Mesut Yilmaz,Rumeysa Colak,Caner Kapar,Mustafa Erman,Fatih Kus,Deniz Tural

MEDICINA-LITHUANIAno. 12 (2024)

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn